02/19/2026 | Press release | Distributed by Public on 02/19/2026 15:52
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Restricted Stock Units | $78.94 | 02/15/2026 | M | 340 | (1) | (1) | Common Stock | 340 | $ 0 | 680 | D | ||||
| Restricted Stock Units | $78.94 | 02/15/2026 | M | 682 | (2) | (2) | Common Stock | 682 | $ 0 | 0 | D | ||||
| Restricted Stock Units | $78.94 | 02/15/2026 | M | 362 | (2) | (2) | Common Stock | 362 | $ 0 | 0 | D | ||||
| Restricted Stock Units | $78.94 | 02/16/2026 | M | 85 | (3) | (3) | Common Stock | 85 | $ 0 | 0 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Krawczyk Joseph R II C/O MICROCHIP TECHNOLOGY INCORPORATED 2355 W CHANDLER BLVD CHANDLER, AZ 85224-6199 |
SR. VP, WW CLIENT ENGAGEMENT | |||
| Deborah L. Wussler, as Attorney-in-Fact | 02/19/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The restricted stock units vest in nine quarterly installments of 338 shares beginning November 15, 2023, and three quarterly installments of 340 shares beginning on February 15, 2026, as long as the individual remains a service provider through the vesting date. Vested shares were delivered to the reporting person upon vest. |
| (2) | The restricted stock units vested in full on February 15, 2026. Vested shares were delivered to the reporting person upon vest. |
| (3) | The restricted stock units will vest in full on February 16, 2026 as long as the individual remains a service provider through the vesting date. Vested shares will be delivered to the reporting person upon vest. |